These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Immunohistochemical characterization of microglia in Nasu-Hakola disease brains. Satoh J, Tabunoki H, Ishida T, Yagishita S, Jinnai K, Futamura N, Kobayashi M, Toyoshima I, Yoshioka T, Enomoto K, Arai N, Arima K. Neuropathology; 2011 Aug; 31(4):363-75. PubMed ID: 21118401 [Abstract] [Full Text] [Related]
3. Immunohistochemical characterization of CD33 expression on microglia in Nasu-Hakola disease brains. Satoh J, Kino Y, Motohashi N, Ishida T, Yagishita S, Jinnai K, Arai N, Nakamagoe K, Tamaoka A, Saito Y, Arima K. Neuropathology; 2015 Dec; 35(6):529-37. PubMed ID: 26087043 [Abstract] [Full Text] [Related]
4. Variable expression of microglial DAP12 and TREM2 genes in Nasu-Hakola disease. Sasaki A, Kakita A, Yoshida K, Konno T, Ikeuchi T, Hayashi S, Matsuo H, Shioda K. Neurogenetics; 2015 Oct; 16(4):265-76. PubMed ID: 26001891 [Abstract] [Full Text] [Related]
5. Gene expression profile of THP-1 monocytes following knockdown of DAP12, a causative gene for Nasu-Hakola disease. Satoh J, Shimamura Y, Tabunoki H. Cell Mol Neurobiol; 2012 Apr; 32(3):337-43. PubMed ID: 22080356 [Abstract] [Full Text] [Related]
6. Nasu-Hakola disease: The first case reported by Nasu and review: The 50th Anniversary of Japanese Society of Neuropathology. Kaneko M, Sano K, Nakayama J, Amano N. Neuropathology; 2010 Oct; 30(5):463-70. PubMed ID: 20500450 [Abstract] [Full Text] [Related]
7. A Shotgun Proteomic Platform for a Global Mapping of Lymphoblastoid Cells to Gain Insight into Nasu-Hakola Disease. De Palma A, Agresta AM, Viglio S, Rossi R, D'Amato M, Di Silvestre D, Mauri P, Iadarola P. Int J Mol Sci; 2021 Sep 15; 22(18):. PubMed ID: 34576123 [Abstract] [Full Text] [Related]
8. A novel mutation in TREM2 gene causing Nasu-Hakola disease and review of the literature. Dardiotis E, Siokas V, Pantazi E, Dardioti M, Rikos D, Xiromerisiou G, Markou A, Papadimitriou D, Speletas M, Hadjigeorgiou GM. Neurobiol Aging; 2017 May 15; 53():194.e13-194.e22. PubMed ID: 28214109 [Abstract] [Full Text] [Related]
9. The Triggering Receptor Expressed on Myeloid Cells 2: A Molecular Link of Neuroinflammation and Neurodegenerative Diseases. Walter J. J Biol Chem; 2016 Feb 26; 291(9):4334-41. PubMed ID: 26694609 [Abstract] [Full Text] [Related]
12. C9ORF72 expansion does not affect the phenotype in Nasu-Hakola disease with the DAP12 mutation. Solje E, Hartikainen P, Valori M, Vanninen R, Tiihonen J, Hakola P, Tienari PJ, Remes AM. Neurobiol Aging; 2014 Jul 26; 35(7):1780.e13-7. PubMed ID: 24612676 [Abstract] [Full Text] [Related]
13. Phenotypic Expansion in Nasu-Hakola Disease: Immunological Findings in Three Patients and Proposal of a Unifying Pathogenic Hypothesis. Errichiello E, Dardiotis E, Mannino F, Paloneva J, Mattina T, Zuffardi O. Front Immunol; 2019 Jul 26; 10():1685. PubMed ID: 31396216 [Abstract] [Full Text] [Related]
16. LC3, an autophagosome marker, is expressed on oligodendrocytes in Nasu-Hakola disease brains. Satoh J, Motohashi N, Kino Y, Ishida T, Yagishita S, Jinnai K, Arai N, Nakamagoe K, Tamaoka A, Saito Y, Arima K. Orphanet J Rare Dis; 2014 May 01; 9():68. PubMed ID: 24886140 [Abstract] [Full Text] [Related]